why choose us

First received: September 05, 2023

Clinical Trial: A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Hypertension Due to Left Heart Disease

Study Type: INTERVENTIONAL


Official Title: First-in-man Single-dose Escalation Study in a Randomized, Single-blind, Placebo-controlled, Group-comparison Design to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAY 2

Brief Summary: Researchers are looking for a better way to treat people who have pulmonary hypertension (PH) due to left heart disease.PH due to left heart disease is a condition of high blood pressure in the vessels of the lungs caused by diseases in the left side of the heart.The study treatment, BAY2701250 is under development and will be tested in humans for the first time in this study.Once it is approved, it may help treat people with PH due to left heart disease.The participants of this study will be healthy and will have…

Read more